Evidence map›Paper›PMID 31417933›Full record

ReviewWorld journal of clinical cases2019

Colorectal neuroendocrine carcinoma: A case report and review of the literature.

Tomoaki Yoshida, Kenya Kamimura, Kazunori Hosaka, Koji Doumori, Hiromitsu Oka, Akito Sato, Yasuo Fukuhara, Shoji Watanabe, Tomomi Sato, Akira Yoshikawa and 2 more

Open access · diamondAbstract readReview
In one paragraph

Review in World journal of clinical cases, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed, 1 pooled it
1.9field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 1 synthesis or guideline pooled it, 24 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Colorectal neuroendocrine tumors: A case series.International journal of surgery case reports · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 1 institution in 1 country.

Tomoaki YoshidaDivision of Gastroenterology and Hepatology, Graduate School of Medical and Dental Sciences, Niigata University, Niigata 951-8510, Japan.
Kenya KamimuraDivision of Gastroenterology and Hepatology, Graduate School of Medical and Dental Sciences, Niigata University, Niigata 951-8510, Japan. kenya-k@med.niigata-u.ac.jp.
Kazunori HosakaDivision of Gastroenterology and Hepatology, Graduate School of Medical and Dental Sciences, Niigata University, Niigata 951-8510, Japan.
Koji DoumoriDivision of Gastroenterology and Hepatology, Nagaoka Chuo General Hospital, Niigata 940-0861, Japan.
Hiromitsu OkaDivision of Gastroenterology and Hepatology, Nagaoka Chuo General Hospital, Niigata 940-0861, Japan.
Akito SatoDivision of Gastroenterology and Hepatology, Nagaoka Chuo General Hospital, Niigata 940-0861, Japan.
Yasuo FukuharaDivision of Gastroenterology and Hepatology, Nagaoka Chuo General Hospital, Niigata 940-0861, Japan.
Shoji WatanabeDivision of Gastroenterology and Hepatology, Nagaoka Chuo General Hospital, Niigata 940-0861, Japan.
Tomomi SatoDivision of Gastroenterology and Hepatology, Nagaoka Chuo General Hospital, Niigata 940-0861, Japan.
Akira YoshikawaDivision of Gastroenterology and Hepatology, Nagaoka Chuo General Hospital, Niigata 940-0861, Japan.
Takashi TomidokoroDivision of Gastroenterology and Hepatology, Nagaoka Chuo General Hospital, Niigata 940-0861, Japan.
Shuji TeraiDivision of Gastroenterology and Hepatology, Graduate School of Medical and Dental Sciences, Niigata University, Niigata 951-8510, Japan.
Niigata University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundColorectal neuroendocrine carcinoma (NEC) is a rare tumor that demonstrates aggressive growth pattern with ingrowth into the tract, metastasis to the other organs, and invasion to the surrounding organs; these clinical characteristics result in poor prognosis. Surgical resection appears as an effective approach; however, because it is difficult to accurately diagnose NEC during the early stage and owing to its aggressive growth pattern, development of a reliable standard chemotherapy regimen and management strategies are essential. CASE SUMMARY: Here, we report the case of patient with NEC showing an aggressive growth pattern that resulted in the rupture of the tumor to the outside the colon after stenting of the internal colonic stenosis. In addition, the tumor invaded into the duodenum, thereby causing duodenal stenosis that required an additional stent in the duodenum. This aggressive growth pattern is one of the main features of the NEC that is different from adenocarcinoma. To clarify the clinical characteristics, we reviewed 60 recently reported cases, including data on tumor location, size, treatment, and prognosis.

conclusionWe consider that the information presented here is of great significance for the diagnosis, treatment, and management of symptoms of the patients with NEC.

Indexed as

Case reportColonColorectal mixed adenoneuroendocrine carcinomaGrowthNeuroendocrine carcinoma

Identifiers

PMID31417933
PMCPMC6692263
OpenAlexW2965437815

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.